Iliaz Raim, Ozpolat Tahsin, Baran Bulent, Demir Kadir, Kaymakoglu Sabahattin, Besisik Fatih, Akyuz Filiz
Department of Gastroenterology, Istanbul School of Medicine, Istanbul University.
Bloodworks Research Institute, Seattle, USA.
Eur J Gastroenterol Hepatol. 2018 Jul;30(7):786-791. doi: 10.1097/MEG.0000000000001111.
Spontaneous bacterial peritonitis (SBP) is a common and high-mortality infectious complication of patients with cirrhosis. New inflammatory markers are associated with morbidity/mortality in various diseases. The aim of our study was to find the 30-day mortality rate of SBP and their predictors.
Seventy patients with cirrhosis complicated with SBP and 55 non-SBP controls were enrolled into the study, and patients were evaluated for mortality rate and its predictors.
The 30-day and 3-month mortality rates in the SBP group were 26.1 and 50.7%, respectively. Mortality rates were higher in the SBP group than in the controls. Symptoms at hospital admission and cell counts in ascitic fluid made no difference in predicting 30-day mortality. Patients with SBP with high serum neutrophil counts, high neutrophil-lymphocyte ratio, high C reactive protein (CRP)/albumin ratio, and high model for end-stage liver disease (MELD) score had higher 30-day mortality rates. We determined optimal cutoff values of MELD scores and serum neutrophil counts for predicting 30-day mortality as 20.5 and 6850/mm, respectively. The sensitivity and specificity for the MELD cutoff value were 83.3 and 80.4%, respectively. We also followed up patients for 60 months after SBP; the patients with high inflammatory markers and MELD scores at the time of SBP diagnosis had worse survival compared with the group with lower levels.
Our results suggest that SBP has high 30-day mortality. MELD scores and inflammatory markers (CRP, CRP albumin ratio, neutrophil-lymphocyte ratio) may be used to predict mortality in patients with SBP.
自发性细菌性腹膜炎(SBP)是肝硬化患者常见且死亡率高的感染性并发症。新的炎症标志物与多种疾病的发病率/死亡率相关。本研究的目的是找出SBP的30天死亡率及其预测因素。
70例肝硬化合并SBP患者和55例非SBP对照纳入研究,对患者进行死亡率及其预测因素评估。
SBP组30天和3个月死亡率分别为26.1%和50.7%。SBP组死亡率高于对照组。入院时症状和腹水细胞计数对预测30天死亡率无差异。血清中性粒细胞计数高、中性粒细胞与淋巴细胞比值高、C反应蛋白(CRP)/白蛋白比值高以及终末期肝病模型(MELD)评分高的SBP患者30天死亡率更高。我们确定预测30天死亡率的MELD评分和血清中性粒细胞计数的最佳截断值分别为20.5和6850/mm³。MELD截断值的敏感性和特异性分别为83.3%和80.4%。我们还在SBP后对患者进行了60个月随访;SBP诊断时炎症标志物和MELD评分高的患者与水平较低的组相比生存情况更差。
我们的结果表明SBP有较高的30天死亡率。MELD评分和炎症标志物(CRP、CRP白蛋白比值、中性粒细胞与淋巴细胞比值)可用于预测SBP患者的死亡率。